128 related articles for article (PubMed ID: 20224307)
1. Myocardial infarction risk in HIV-infected patients: epidemiology, pathogenesis, and clinical management.
Calza L; Manfredi R; Verucchi G
AIDS; 2010 Mar; 24(6):789-802. PubMed ID: 20224307
[No Abstract] [Full Text] [Related]
2. Anti-HIV agents. Controversial findings on abacavir and heart attacks.
TreatmentUpdate; 2008 Mar; 20(2):1-5. PubMed ID: 18661643
[No Abstract] [Full Text] [Related]
3. Heart attack risk with abacavir and didanosine.
AIDS Patient Care STDS; 2008 Apr; 22(4):346-7. PubMed ID: 18434947
[No Abstract] [Full Text] [Related]
4. FDA notifications. Large study suggests heart attack risk from use of abacavir or didanosine.
AIDS Alert; 2008 May; 23(5):58-9. PubMed ID: 18642404
[No Abstract] [Full Text] [Related]
5. Longitudinal evaluation of cardiovascular disease-associated biomarkers in relation to abacavir therapy.
Hammond E; McKinnon E; Mallal S; Nolan D
AIDS; 2008 Nov; 22(18):2540-3. PubMed ID: 19005279
[No Abstract] [Full Text] [Related]
6. FDA notifications. Ongoing safety review of abacavir, possible MI risk.
AIDS Alert; 2011 May; 26(5):58-9. PubMed ID: 21649950
[No Abstract] [Full Text] [Related]
7. Class of antiretroviral drugs and the risk of myocardial infarction.
; Friis-Møller N; Reiss P; Sabin CA; Weber R; Monforte Ad; El-Sadr W; Thiébaut R; De Wit S; Kirk O; Fontas E; Law MG; Phillips A; Lundgren JD
N Engl J Med; 2007 Apr; 356(17):1723-35. PubMed ID: 17460226
[TBL] [Abstract][Full Text] [Related]
8. Abacavir-induced agranulocytosis in two Taiwanese patients tested HLA-B*5701-negative.
Chen SJ; Yang SP; Hung CC; Fung CP
AIDS; 2010 May; 24(8):1238-9. PubMed ID: 20421748
[No Abstract] [Full Text] [Related]
9. Parsonage-Turner syndrome: a rare case of abacavir hypersensitivity reaction in HIV-infected patients.
Bellagamba R; Tommasi C; De Marco M; Narciso P
J Infect; 2008 Jul; 57(1):88-90. PubMed ID: 18514915
[No Abstract] [Full Text] [Related]
10. Abacavir and risk of myocardial infarction in HIV-infected patients on highly active antiretroviral therapy: a population-based nationwide cohort study.
Obel N; Farkas DK; Kronborg G; Larsen CS; Pedersen G; Riis A; Pedersen C; Gerstoft J; Sørensen HT
HIV Med; 2010 Feb; 11(2):130-6. PubMed ID: 19682101
[TBL] [Abstract][Full Text] [Related]
11. Abacavir use and risk of acute myocardial infarction and cerebrovascular events in the highly active antiretroviral therapy era.
Bedimo RJ; Westfall AO; Drechsler H; Vidiella G; Tebas P
Clin Infect Dis; 2011 Jul; 53(1):84-91. PubMed ID: 21653308
[TBL] [Abstract][Full Text] [Related]
12. Abacavir controversy continues to brew.
Dalton P
Proj Inf Perspect; 2008 Sep; (46):4-7. PubMed ID: 19043874
[No Abstract] [Full Text] [Related]
13. Antiretroviral drugs and the risk of myocardial infarction.
Zangerle R; Sarcletti M
N Engl J Med; 2007 Aug; 357(7):715-6; author reply 716-7. PubMed ID: 17703532
[No Abstract] [Full Text] [Related]
14. Antiretroviral drugs and the risk of myocardial infarction.
Pollack TM; Rind DM
N Engl J Med; 2007 Aug; 357(7):716; author reply 716-7. PubMed ID: 17703531
[No Abstract] [Full Text] [Related]
15. Sweet's syndrome following abacavir therapy.
Del Giudice P; Vandenbos F; Perrin C; Bernard E; Marq L; Dellamonica P
J Am Acad Dermatol; 2004 Sep; 51(3):474-5. PubMed ID: 15337997
[No Abstract] [Full Text] [Related]
16. Implementing the number needed to harm in clinical practice: risk of myocardial infarction in HIV-1-infected patients treated with abacavir.
Kowalska JD; Kirk O; Mocroft A; Høj L; Friis-Møller N; Reiss P; Weller I; Lundgren JD
HIV Med; 2010 Mar; 11(3):200-8. PubMed ID: 19863618
[TBL] [Abstract][Full Text] [Related]
17. Antiretroviral drugs and the risk of myocardial infarction.
Kaplan RC; Tien PC; Lazar J
N Engl J Med; 2007 Aug; 357(7):715; author reply 716-7. PubMed ID: 17699825
[No Abstract] [Full Text] [Related]
18. Impact of individual antiretroviral drugs on the risk of myocardial infarction in human immunodeficiency virus-infected patients: a case-control study nested within the French Hospital Database on HIV ANRS cohort CO4.
Lang S; Mary-Krause M; Cotte L; Gilquin J; Partisani M; Simon A; Boccara F; Costagliola D;
Arch Intern Med; 2010 Jul; 170(14):1228-38. PubMed ID: 20660842
[TBL] [Abstract][Full Text] [Related]
19. Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients.
;
AIDS; 2008 Sep; 22(14):F17-24. PubMed ID: 18753925
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of telomerase activity by human immunodeficiency virus (HIV) nucleos(t)ide reverse transcriptase inhibitors: a potential factor contributing to HIV-associated accelerated aging.
Leeansyah E; Cameron PU; Solomon A; Tennakoon S; Velayudham P; Gouillou M; Spelman T; Hearps A; Fairley C; Smit de V; Pierce AB; Armishaw J; Crowe SM; Cooper DA; Koelsch KK; Liu JP; Chuah J; Lewin SR
J Infect Dis; 2013 Apr; 207(7):1157-65. PubMed ID: 23303810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
